liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond
University of Camerino, Italy.
Lilly Research Laboratories, Indianapolis, IN, USA.
Oregon Health & Science University, Portland, OR, USA.
Oregon Health & Science University, Portland, OR, USA.
Show others and affiliations
2009 (English)In: Alcohol, ISSN 0741-8329, E-ISSN 1873-6823, Vol. 43, no 7, 491-498 p.Article in journal (Refereed) Published
Abstract [en]

This article summarizes the proceedings of a symposium held at the conference on "Alcoholism and Stress: A Framework for Future Treatment Strategies" in Volterra, Italy, May 6-9, 2008. Chaired by Markus Heilig and Roberto Ciccocioppo, this symposium offered a forum for the presentation of recent data linking neuropetidergic neurotransmission to the regulation of different alcohol-related behaviors in animals and in humans. Dr. Donald Gehlert described the development of a new corticotrophin-releasing factor receptor 1 antagonist and showed its efficacy in reducing alcohol consumption and stress-induced relapse in different animal models of alcohol abuse. Dr. Andrey Ryabinin reviewed recent findings in his laboratory, indicating a role of the urocortin 1 receptor system in the regulation of alcohol intake. Dr. Annika Thorsell showed data supporting the significance of the neuropeptide Y receptor system in the modulation of behaviors associated with a history of ethanol intoxication. Dr. Roberto Ciccocioppo focused his presentation on the nociceptin/orphanin FQ (N/OFQ) receptors as treatment targets for alcoholism. Finally, Dr. Markus Heilig showed recent preclinical and clinical evidence suggesting that neurokinin 1 antagonism may represent a promising new treatment for alcoholism. Collectively, these investigators highlighted the significance of neuropeptidergic neurotransmission in the regulation of neurobiological mechanisms of alcohol addiction. Data also revealed the importance of these systems as treatment targets for the development of new medication for alcoholism.

Place, publisher, year, edition, pages
Elsevier, 2009. Vol. 43, no 7, 491-498 p.
Keyword [en]
CRH; Nociceptin/orphanin FQ; Neurokinins; Substance P; Neuropeptide Y; Urocortin
National Category
Neurosciences
Identifiers
URN: urn:nbn:se:liu:diva-101848DOI: 10.1016/j.alcohol.2009.08.003PubMedID: 19913192OAI: oai:DiVA.org:liu-101848DiVA: diva2:666745
Available from: 2013-11-24 Created: 2013-11-24 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Authority records BETA

Thorsell, AnnikaHeilig, Markus

Search in DiVA

By author/editor
Thorsell, AnnikaHeilig, Markus
In the same journal
Alcohol
Neurosciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 133 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf